COVID‐19 diagnostics for resource‐limited settings: Evaluation of “unextracted” qRT‐PCR
- 23 July 2020
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (1) , 559-563
Abstract
The coronavirus disease 2019 (COVID‐19) pandemic has created a precipitous increase in the need for molecular diagnostics. Unfortunately, access to RNA extraction reagents can represent a bottleneck for quantitative real‐time reverse transcriptase‐polymerase chain reaction (qRT‐PCR)‐based methodologies, stemming from both extraordinary supply‐chain stresses and the global reach of the virus into resource‐limited settings. To provide flexible diagnostic options for such environments, we report here an “unextracted modification” for qRT‐PCR using the Centers for Disease Control's (CDC's) widely utilized primers/probe sets for severe acute respiratory syndrome coronavirus 2 (N1/N2/N3 targeting viral nucleocapsid and RP‐control targeting human RNase P). This approach replaces RNA extraction/purification with a heat‐inactivation step of viral transport media (VTM), followed by direct inoculation—with or without VTM spin concentration—into PCR master mixes. Using derivatives of care from our clinical workflow, we compared traditional and unextracted CDC methodologies. Although some decrease in analytic sensitivity was evident (by higher Ct values) without extraction, in particular for the N2 primer/probe‐set, we observed high categorical positive agreement between extracted and unextracted results for N1 (unconcentrated VTM‐38/40; concentrated VTM‐39/41), N3 (unconcentrated VTM‐38/40; concentrated VTM‐41/41), and RP (unconcentrated and concentrated VTM‐81/81). The negative categorical agreement for N1/N2/N3 was likewise high. Overall, these results suggest that laboratories could adapt and validate unextracted qRT‐PCR protocols as a contingency to overcome supply limitations, with minimal impact on categorical results.Keywords
Funding Information
- National Human Genome Research Institute (R42HG009470)
This publication has 14 references indexed in Scilit:
- Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2Annals of Internal Medicine, 2020
- Stability of SARS-CoV-2 in different environmental conditionsThe Lancet Microbe, 2020
- Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19mBio, 2020
- Diagnostic Testing for the Novel CoronavirusJAMA, 2020
- SARS-CoV-2 TestingAmerican Journal of Clinical Pathology, 2020
- Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the OutbreakClinical Chemistry, 2020
- A novel coronavirus outbreak of global health concernThe Lancet, 2020
- Laboratory diagnosis of emerging human coronavirus infections – the state of the artEmerging Microbes & Infections, 2020
- Detection of Single-Nucleotide Polymorphism Markers of Antimalarial Drug Resistance Directly from Whole BloodThe Journal of Molecular Diagnostics, 2019
- Development of a TaqMan® RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya virusesJournal of Virological Methods, 2005